Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rMenB+OMV NZ Vaccine in Healthy Infants in the Republic of Korea
NCT06113198Phase 4Active, not recruiting
- Sponsor
- GSK
- Start
- Nov 2023
- Primary completion
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Multicomponent meningococcal B vaccine in meningococcal meningitis, sponsored by GSK. Started Nov 2023; status: active, not recruiting.
02
Drugs
Multicomponent meningococcal B vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT06113198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06113198.